Can we Predict the Clinical Course of Immune Thrombocytopenia in Children by The Mean Platelet Volume? A Preliminary

Clinical Laboratory
|March 19, 2021
PubMed

Insights

Mean platelet volume (MPV) can predict immune thrombocytopenia (ITP) chronicity in children. An initial MPV above 8.7 fL suggests chronic ITP, while MPV changes also offer prognostic value.

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Clinical Diagnostics

Background:

  • Mean platelet volume (MPV) is a marker of platelet activation.
  • MPV levels are elevated in immune thrombocytopenia (ITP).
  • Predicting the clinical course of ITP in children is crucial for management.

Purpose of the Study:

  • To evaluate the predictive value of MPV for the clinical course of pediatric ITP.
  • To determine if MPV can differentiate between acute and chronic ITP in children.

Main Methods:

  • Retrospective analysis of 36 children with ITP and 36 healthy controls.
  • Stratification into healthy controls, newly diagnosed/persistent ITP, and chronic ITP groups.
  • Measurement and comparison of hematological indices, including MPV.

Main Results:

  • Median MPV was significantly higher in children with ITP (8.15-8.65 fL) compared to healthy controls (7.20 fL).
  • An MPV cutoff of 8.7 fL differentiated chronic ITP from other groups.
  • MPV change over three months was significantly different between acute and chronic ITP cases.

Conclusions:

  • Initial MPV > 8.7 fL may predict chronicity in pediatric ITP.
  • MPV at diagnosis and its change over time are potential prognostic markers for ITP course in children.
Abstract